Workflow
Anti - Aging
icon
Search documents
Visionary Holdings (NASDAQ: GV) Provides 2026–2027 Growth Outlook; RAMU Anti-Aging Product Line Targets Potential $30 Million Annual Sales
Globenewswire· 2026-03-05 14:30
Core Insights - Visionary Holdings Inc. is focusing on expanding its presence in the global healthcare and medical aesthetics markets, particularly in North America and Europe, as part of its strategic growth priorities for 2026-2027 [1][2][4] Business Outlook - The period from 2026 to 2027 is expected to be crucial for the commercialization of the RAMU anti-aging product line, which is anticipated to drive significant revenue growth [4][9] - Management estimates that RAMU-related product sales could potentially reach approximately US$30 million annually, depending on market conditions and operational execution [5] Strategic Growth Priorities - The company plans to continue its expansion into international medical aesthetics markets through product commercialization, distribution partnerships, and healthcare service collaborations [7] - Visionary aims to accelerate the commercialization of its RAMU anti-aging product line, targeting premium applications in medical aesthetics and regenerative healthcare [7] - Development of integrated healthcare service platforms that combine medical aesthetics products, wellness services, and advanced biotechnology applications is also a priority [8] Management Commentary - The CEO of Visionary Holdings emphasized the importance of the upcoming period for the company's strategic transition towards healthcare services and medical aesthetics, highlighting the potential for meaningful growth opportunities [9][10]
CORRECTION – Visionary Holdings Inc.
Globenewswire· 2026-01-14 03:36
Core Viewpoint - Visionary Holdings Inc. has released its final annual report for fiscal year 2025, highlighting a strategic transformation towards health management, anti-aging, and premium medical aesthetics, with initial revenue contributions from emerging health businesses indicating early progress in this transition [1][3][14]. Financial Performance - Total revenue for fiscal year 2025 was USD 5.04 million, a decrease of 46.2% year-over-year, primarily due to a contraction in real estate leasing operations and changes in the education policy environment [3]. - The company reported a net loss of USD 15.75 million, largely due to one-time transformation-related investments and asset impairment charges totaling approximately USD 4.70 million [4]. - Gross margin improved to 28.0%, with the education services segment achieving a gross margin of 64.4%, indicating stability in core operating efficiency [5]. - Cash flow from investing activities was USD 14.51 million, mainly from asset dispositions, while operating cash outflows decreased to USD 2.97 million from USD 4.10 million in the previous fiscal year [5]. Business Developments - Emerging health-related businesses contributed approximately 21.1% of total revenue, marking the early implementation stage of the company's business restructuring [3]. - Real estate leasing revenue was USD 2.80 million, education services revenue was USD 1.18 million, and life sciences and health-related businesses generated USD 1.06 million [8]. - The company is pursuing initiatives in health management and anti-aging, focusing on gastrointestinal health management and service-oriented offerings, with early-stage commercialization efforts in Asia [9]. - Strategic collaborations have been established with industry participants to enhance access to proprietary technologies and expand the global premium medical aesthetics service network [11]. Strategic Focus - The company aims to advance its development in high-potential segments within premium medical aesthetics and cellular rejuvenation-related businesses, with plans for commercialization and market expansion over the next two years [15]. - The AI education business remains stable, continuing to offer various educational programs while cooperating with Canadian public institutions [12]. - Future plans include optimizing the AI education ecosystem, enhancing digital student management systems, and expanding marketing efforts in key Asian markets [20].
Functional Brands Inc. Launches Kirkman's(R) Skin, Beauty & Anti-Aging Bundle: A Science-Backed Approach to Radiant, Resilient Skin
TMX Newsfile· 2025-12-22 13:00
Core Insights - Functional Brands Inc. has launched the Skin, Beauty & Anti-Aging Bundle by Kirkman®, aimed at promoting healthy skin through detoxification, cellular renewal, and protection against environmental stressors [1][6] Product Composition - The bundle includes four key ingredients: Reduced Glutathione, Zinc Cream, Biotin, and Grapefruit Seed Extract, each selected for their clinically supported benefits in skin health and anti-aging [1][6] Ingredient Benefits - **Reduced Glutathione**: Acts as a master antioxidant, neutralizing free radicals and reducing oxidative stress, which contributes to premature skin aging. It supports liver detoxification, enhancing skin clarity and texture [2] - **Zinc Cream**: A topical treatment that soothes irritated skin, promotes wound healing, and supports collagen synthesis. It has antimicrobial and anti-inflammatory properties, effective in reducing acne lesions and improving skin barrier function [3] - **Biotin**: Essential for cellular energy metabolism and keratin production, biotin supplementation improves hair thickness, nail strength, and skin hydration. It has been shown to reduce brittle nails and enhance scalp condition [4] - **Grapefruit Seed Extract**: Provides antioxidant and antimicrobial benefits, protecting skin from environmental toxins. It helps prevent oxidative damage and supports a balanced skin microbiome [5] Availability - The Skin, Beauty & Anti-Aging Bundle by Kirkman® is available for purchase through Kirkman's website and practitioners [6][7]